News Articles 71 - 80 of 160

Hepatitis B vaccine shortage PHE letter - plan for phased re-introduction of hepatitis B vaccine for lower priority groups
News Type: BASL News

Public Health England (PHE) has recently published a recovery plan on to support re-introduction of hepatitis B vaccine in a phased approach during 2018 for lower priority groups mainly vaccinated by occ health and primary care.

View a letter from PHE here:  Download PHE letter to stakeholders _hepB vaccine recovery plan 2018.pdf

The link to the recovery plan on the website can be found > here

Intercept Practice to Policy in PBC Health Awards Programme
News Type: BASL News

Welcome to the Europe and Canada Practice to Policy® Health Awards Programme

In 2018, Intercept is excited to offer grant support to local and national projects within eligible countries across Europe and Canada. The Europe and Canada Practice to Policy® Health Awards Programme encourages the development of innovative projects which improve the lives of people with primary biliary cholangitis (PBC).

The application window is now open.

Please note that the deadline for applying is Wednesday 6 June 2018.

Visit the website here - .

Vacancy - Consultant Physician Hepatologist x 2 - Birmingham - closing date 31 March 2018
News Type: BASL News

Job Reference: 304-18C011
Employer: University Hospitals Birmingham NHS Foundation Trust - Medical & Dental
Department: Hepatology
Location: Birmingham, Queen Elizabeth Hospital
Salary: £76,761 - £103.490
Closing Date: 31 March 2018

Applications are invited for 2 x 1.0 WTE Hepatology Consultants (10 PAs) to join the existing liver medicine team. The successful applicants will work as Transplant Physicians within the Department of Hepatology. The department consists of 14 Consultant Hepatologists (including 6 Transplant Physicians and 6 Academic Hepatologists), 3 Hepatology Fellows and 8 specialist hepatology trainees. The successful applicant will contribute to clinical service development and delivery as a member of the hepatology team, working closely with colleagues in the Liver and Hepatobiliary Unit, Interventional Radiology and Oncology.

Full details can be found on the NHS Jobs site > here.

ACCEA 2018 Round Open - Apply for BASL support
News Type: BASL News

The Advisory Committee on Clinical Excellence Awards (ACCEA) opened the 2018 awards round on Tuesday 13th February. The final closing date for applications to the ACCEA is 17:00 on Thursday 12th April.

Application for BASL support
If you would like to apply for BASL support, please complete and submit a copy of your ACCEA Application Form to BASL, along with any other supplementary CVQs as detailed below:

  • Supplementary CV Questionnaire: Research & Innovation Assessment
  • Supplementary CV Questionnaire: Teaching & Training Assessment
  • Supplementary CV Questionnaire: Medical Leadership & Managing a High Quality Service Assessment.

Please be aware that there is a maximum number of supplementary forms that can be completed at each National Level: Bronze and Silver applicants: 1 and Gold applicants: 2. These forms are optional and it is for the applicant to decide whether using them will increase chances of success.

Full application guidance can be found on the ACCEA website including the use of the Supplementary Forms by clicking here.

In addition BASL requires a short piece to accompany your application stating why you feel you should be supported by BASL.

The deadline for applying for BASL support is 17:00 on Friday 16th March 2018.

All applications must go through the ACCEA on line system, should you need a downloadable form to send to BASL these can be found on the ACCEA website by clicking here.

As in previous years BASL are able to support colleagues directly by nomination for national Gold, Silver and Bronze awards. As a specialist society, BASL cannot make nominations for Platinum awards; this must be done through the applicant’s University/Research Body and Universities UK. BASL can however provide a citation to support an application for a Platinum award.

To apply for BASL support, please follow the steps below:

1. Send a completed ACCEA Application Form, along with a short piece as to why you feel you should be supported by BASL, to the BASL Secretariat, by 17:00 on Friday 16th March 2018.

Please understand that in fairness to all applicants, late submissions will not be considered.

2. All applicants are asked to provide the name of an individual who could write a supporting citation when submitting their application to BASL. ACCEA regard the citations provided in support of individuals as giving added value to the process. The citation MAY be stronger if it comes from outside ones institution.

3. You must submit your own application to ACCEA online by their deadline 17:00 on Thursday 12th April 2018. This is your own responsibility. .

4. If you are in receipt of BASL support then BASL will upload your citation. You must ensure that your application is uploaded to the ACCEA website at least one week before the deadline - 17:00 on Thursday 5th April 2018, so that BASL has sufficient time to upload your citations onto your application on the ACCEA website.

BVHG and BASL Best Practice for ODN Stakeholders Meeting report
News Type: BASL News

Read the summary of the report from the first BVHG and BASL Best Practice for ODN Stakeholders Meeting which was held on the 10–11 January 2018 in Manchester on the BVHG page of the website by clicking here.

The report highlights the limitations of the current HCV treatment model, and provides suggestions on how it can be modified and improved. The report describes best practice examples for eliminating HCV for ODNs to take and adapt to work in their area. The intention is that this information will provide all ODNs with a framework to develop the 5-year plans needed to meet their CQUIN requirement, and importantly to also leave them well placed to deliver on the World Health Organisations goal of HCV elimination by 2030.

Vacancy - Alcohol Health Alliance: Policy and Advocacy Manager
News Type: BASL News

Alcohol Health Alliance - Policy and Advocacy Manager 

For the Alcohol Health Alliance UK based at the Institute of Alcohol Studies
Salary £35,000 per year including London weighting
Fixed 24-month contract

A copy of the Job Description and details on how to apply can be downloaded here:  Download Job Description policy manager AHA Feb 2018 with interview dates.pdf

Or viewed on the AHA website: .

Apply for this role

To apply for this role, please send a CV and cover letter outlining how you meet the criteria to Kellie Donaldson at .

The deadline for applications is 5pm Friday 23rd February 2018.

First interviews will be held on Wednesday 7th March 2018 and successful candidates will be invited back for final interviews on Monday 19th March 2018.

UKLPG Research Subcommittee - Update
News Type: BASL News

The UK Liver Pathology Group (UKLPG) was formed in 2016, evolving from the UK Liver EQA Scheme and the Liver subcommittee of the Pathology Section of the BSG, with the purpose of promoting excellence in liver histopathology services in the UK and Ireland, across all levels of specialisation, through professional collaboration in education, quality assurance and research.

The Research subcommittee aims to act as a source of histopathological advice for clinicians and scientists undertaking clinical, translational or pre-clinical research (including animal modelling), particularly those lacking local pathological support and resources.

The subcommittee welcome enquiries by email to .

UKLPG Research subcommittee
Dr Dina Tiniakos (Chair), Newcastle University
Prof Rob Goldin, Imperial College London
Dr Tu Vinh Luong, Royal Free London
Dr Tim Kendall, University of Edinburgh
Dr Ben Challoner, Guy's and St Thomas' NHS Foundation Trust

For details about the UKLPG, please see our website: .

Download a copy of the information as a flyer here to share amongst colleagues;  Download UKLPG Research subcommittee.pdf

Vacancy - Clinical Research Associate in Hepatology (Autoimmune Liver Disease)
News Type: BASL News

Clinical Research Associate in Hepatology (Autoimmune Liver Disease)
Salary: £28,641 - £48,123 per annum
Closing date: 2 March 2018

Applications are invited for the post of Clinical Research Associate based in the Institute of Cellular Medicine (ICM) at Newcastle University, to pursue a programme of research in liver disease with a particular focus on Autoimmune Liver Disease. You will benefit from working in a group with an international reputation for its research and clinical practice in liver disease and from close interaction with the Stratified Medicine, Biomarkers and Therapeutics and Inflammation, Immunology and Immunotherapy themes in ICM. You will also be appointed an Honorary Registrar at Newcastle upon Tyne Hospitals NHS Foundation Trust contributing to specialist liver clinics and taking part in the out of hours tertiary liver unit on call rota. This will give you tertiary liver unit experience.

You will be expected to have some experience with audit and/or research and to be undertaking or completed higher specialist training in gastroenterology/hepatology. The key attribute, however, is enthusiasm to realise the opportunities offered by the post.

You must be in possession of MRCP or equivalent, with a valid full GMC Registration to eligible to apply.

This is a 2 year post with the potential to extend to a third year.

Those interested are strongly encouraged to contact either: Professor David Jones, email: or Dr Jess Dyson, e-mail: to discuss the post.

To apply, please visit the Newcastle University vacancies website.  
Ref: A109780R

The UK Obstetric Surveillance System (UKOSS) is collecting data during pregnancy for women with Cirrhosis who become pregnant
News Type: BASL News

The UK Obstetric Surveillance System (UKOSS) is collecting data during pregnancy for women with Cirrhosis who become pregnant. This is an attempt to gather data on both numbers and outcomes of women with Pregnancy and Chronic Liver Disease in the UK.

The lead investigators are Professor Cath Williamson and Professor Michael Heneghan.

The ask from Hepatologists & BASL Membership is to let patients know who are pregnant to ask their local Obstetric service to include them in the data collection for the UKOSS Study.

Thank you for your help. 

Awareness Of Drinking Guidelines Remains Low, 2 Years After Their Release
News Type: BASL News

Government and the alcohol industry are failing to provide drinkers with the information they need to make the right choices about alcohol – both for themselves and for their children.

New figures released show that only 16% people are aware of the weekly alcohol guidelines, 2 years after the guidelines were announced.

They also reveal that parents are not equipped with the right information to keep their children safe from alcohol harm, with fewer than 1 in 20 aware of the official advice on children’s drinking.

The figures come from the Alcohol Health Alliance UK (AHA), who surveyed the UK public on their attitudes to alcohol in September 2017.

The low-risk weekly drinking guideline for adults is 14 units a week – around 6 pints of 4% beer, or 6 medium glasses of wine. This guideline was announced by the UK’s Chief Medical Officers in January 2016.

For children, the official advice is that an alcohol-free childhood is best, due to evidence of a wide range of short term and long term harms linked to children’s drinking.

In England, the Chief Medical Officer says that if children do try alcohol, they should be at least 15 years old, and be in a supervised environment.

The recommendation that an alcohol-free childhood free is best is based on the fact that young people are physically unable to tolerate alcohol as well as adults, and young people who drink are more likely to engage in unsafe sex, try drugs, and fall behind in school.

In addition, the younger someone starts drinking, the more likely they are to develop a problem with alcohol when they are older.

This goes against the commonly held view that allowing children to drink at home at a young age will teach them to be responsible drinkers when they are adults. The AHA survey found that this view was common, with 6 in 10 people agreeing that children who drink at home will ‘know how to handle their drink when they’re older’, and that children who drink in moderation at home ‘are less likely to binge on their own.’

Whilst awareness of the alcohol guidelines for both adults and children is low, the AHA’s survey found that there is an appetite among the public for greater information on the risks linked with drinking, with high levels of support for the inclusion of warning messages on alcohol labels.

Eight out of 10 people want alcohol labels to include the weekly guidelines, and a warning that exceeding the guidelines can damage your health.

80% of people also want labels to include a warning that alcohol is linked with cancer. Alcohol is known to be linked with at least seven types of cancer, and has been classed as a class 1 carcinogen, along with tobacco, by the UN-linked International Agency for Research on Cancer. The alcohol industry has been found to mislead the public on this link, by denying or distracting away from it*, and industry bodies recently lobbied successfully in Canada to have a trial of cancer labels on alcohol products halted.

Commenting on the results of the AHA’s polling, Professor Sir Ian Gilmore, chair of the AHA, said that more should be done to ensure the guidelines for both adults and children are communicated to the public. He said:

‘It is really disappointing that only 16% of the public are aware of the alcohol guidelines for adults, and that fewer than 1 in 20 are aware of the advice around children’s drinking. The public have the right to know the Chief Medical Officers’ guidelines, so that they are empowered to make informed choices about their drinking. The same applies to parents, who want to do the right thing by their children and deserve to be informed of the Chief Medical Officers’ guidance on children and alcohol.

‘It is clear from our polling that the public want to be informed of the risks linked with alcohol, including the link with cancer, and that they want to see clear warning information on alcohol labels about the drinking guidelines and the risks of drinking at levels above these guidelines.

‘To this end, the government should introduce mandatory labelling of all alcoholic products, to ensure that the public and parents are fully informed about the risks.

‘In addition, the government should develop national information campaigns, informing the public and parents of the guidelines for both adults and children.’

Commenting on the survey’s findings around alcohol and cancer, Caroline Moye, Head of World Cancer Research Fund UK (WCRF UK), said:
‘AHA’s new research shows a clear public call for alcohol product labels to carry a warning about the link between alcohol and cancer, and the Government should put these warning labels in place. Government cannot leave the communication of cancer risks to the alcohol industry.

‘For anyone who drinks alcohol, we recommend they stay within the weekly guideline of 14 units a week, though abstaining from alcohol altogether will reduce their cancer risk even more. We have many tips for cutting down on alcohol, including drinking out of smaller glasses, diluting drinks such as swapping pints for a spritzer and aiming to keep at least a few days each week alcohol-free. People can get more information about our Cancer Prevention Recommendations at' 

The AHA’s polling was carried out in September 2017. 2,000 people across the UK (1,671 in England, 165 in Scotland, 110 in Wales and 54 in Northern Ireland) were surveyed on the AHA’s behalf by the national polling company OnePoll, and the results were then weighted to ensure they are nationally representative.

OnePoll works according to the Market Research Society’s code of conduct. This code helped ensure, for example, that none of the survey questions could be considered as leading.

Key statistics from the polling include:
- Only 16% of people are aware of the low-risk weekly drinking guideline of 14 units
- Only 3% of people are aware of the guidance that an alcohol-free childhood is best
- Only 10% of people mention cancer when asked which diseases and illnesses are linked to alcohol
- 81% believe the weekly guidelines should appear on alcohol labels
- 78% believe labels should include a warning that exceeding the guidelines can damage your health
- 77% of people support a cancer warning on alcohol product labels
- 73% believe labels should include calorie information
- 55% of people believe that ‘providing children with alcohol in a supervised situation will ensure that they know how to handle drinking when they’re older’.
- 57% of people believe that ‘children that drink alcohol in moderation with their own family are less likely to binge on their own’.
- 77% of people believe that the UK has an ‘unhealthy’ relationship with alcohol
- 52% think that the government is not doing enough to tackle the problems with alcohol in society

The Alcohol Health Alliance UK (AHA) is a group of over 50 organisations including the Royal College of Physicians, Royal College of GPs, British Medical Association, Alcohol Concern and the Institute of Alcohol Studies. 

For further information, please contact Matt Chorley, the AHA’s Policy and Communications Officer, at  or on 0203 075 1726.